OXCARBAZEPINA 300 MG COM REV CT BL AL PLAS TRANS X 30

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1235202110037
  • GGREM 529915201119112
  • Código de barras 7897076911827

O que a fonte publica

Detentor do registro
RANBAXY FARMACÊUTICA LTDA
Princípios ativos
OXCARBAZEPINA
Embalagem
300 MG COM REV CT BL AL PLAS TRANS X 30
Regime de dispensação
Tarja Vermelha
Tipo de produto
Genérico
Classe terapêutica
N3A - ANTIEPILÉPTICOS
Prescrição
Sob prescrição ou restrito

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:529915201119112
{
  "name": "OXCARBAZEPINA 300 MG COM REV CT BL AL PLAS TRANS X 30",
  "holder": "RANBAXY FARMACÊUTICA LTDA",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7897076911827"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "529915201119112",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "73.663.650/0001-90",
  "priceRegime": "Regulado",
  "productName": "OXCARBAZEPINA",
  "productType": "Genérico",
  "hospitalOnly": false,
  "presentation": "300 MG COM REV CT BL AL PLAS TRANS X 30",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "44.92",
    "icms-12": "51.05",
    "icms-17": "54.12",
    "icms-18": "54.78",
    "icms-19": "55.46",
    "icms-20": "56.15",
    "icms-21": "56.86",
    "icms-22": "57.59",
    "icms-23": "58.34",
    "icms-17.5": "54.45",
    "icms-19.5": "55.80",
    "icms-20.5": "56.50",
    "icms-22.5": "57.96",
    "icms-12-alc": "50.43",
    "icms-17-alc": "53.47",
    "icms-18-alc": "54.12",
    "icms-19-alc": "54.79",
    "icms-20-alc": "55.48",
    "icms-21-alc": "56.18",
    "icms-22-alc": "56.90",
    "icms-23-alc": "57.64",
    "withoutTaxes": "44.38",
    "icms-17.5-alc": "53.80",
    "icms-19.5-alc": "55.13",
    "icms-20.5-alc": "55.83",
    "icms-22.5-alc": "57.27"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "OXCARBAZEPINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "61.92",
    "icms-12": "70.37",
    "icms-17": "74.60",
    "icms-18": "75.51",
    "icms-19": "76.45",
    "icms-20": "77.40",
    "icms-21": "78.38",
    "icms-22": "79.38",
    "icms-23": "80.42",
    "icms-17.5": "75.05",
    "icms-19.5": "76.91",
    "icms-20.5": "77.88",
    "icms-22.5": "79.89",
    "icms-12-alc": "69.72",
    "icms-17-alc": "73.92",
    "icms-18-alc": "74.82",
    "icms-19-alc": "75.74",
    "icms-20-alc": "76.70",
    "icms-21-alc": "77.67",
    "icms-22-alc": "78.66",
    "icms-23-alc": "79.68",
    "withoutTaxes": "61.35",
    "icms-17.5-alc": "74.38",
    "icms-19.5-alc": "76.21",
    "icms-20.5-alc": "77.18",
    "icms-22.5-alc": "79.17"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "OXCARBAZEPINA"
  ],
  "therapeuticClass": "N3A - ANTIEPILÉPTICOS",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1235202110037",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "N3A",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:529915201119112"